Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$353.85 - $487.79 $234,956 - $323,892
-664 Closed
0 $0
Q4 2021

Jan 14, 2022

SELL
$456.15 - $525.06 $30,562 - $35,179
-67 Reduced 9.17%
664 $344,000
Q3 2021

Oct 22, 2021

BUY
$444.87 - $538.88 $81,856 - $99,153
184 Added 33.64%
731 $354,000
Q2 2021

Jul 13, 2021

SELL
$387.35 - $450.26 $25,177 - $29,266
-65 Reduced 10.62%
547 $246,000
Q1 2021

Apr 14, 2021

SELL
$314.62 - $411.0 $30,832 - $40,278
-98 Reduced 13.8%
612 $234,000
Q4 2020

Jan 14, 2021

BUY
$246.9 - $321.87 $175,299 - $228,527
710 New
710 $225,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.88B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Gateway Investment Advisers LLC Portfolio

Follow Gateway Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.